Agar and broth microdilution MICs of RP 74501-RP 74502, a mixture of streptogramin antimicrobial agents that inhibited 90% of 22 Legionella strains tested, were 0.64 and 0.08 ,ug/ml, respectively; respective erythromycin values were 1.0 and 0.12 ,ug/ml. RP 74501-RP 74502 at 1 ,ug/ml was more active than the same erythromycin concentration in a macrophage system for both L. pneumophila strains studied but at a lower concentration (0.25 ,ug/ml) was much less active than erythromycin.
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RP 74501-RP 74502 is a purified form of pristinamycin, a streptogramin antibiotic (1, 2, 10, 11, 14) . RP 74501-RP 74502 is a fixed-combination drug composed of approximately 30% RP 74501 (P1 component) and 70% RP 74502 (P2 component), and is given orally. The combination acts synergistically against most gram-positive cocci and some gramnegative bacilli (13) . We tested the effect on Legionella species of RP 74501-RP 74502 by using a variety of susceptibility testing methods designed to determine whether the drug is active against intracellular and extracellular legionellae.
All legionellae studied were clinical isolates. These strains were identical to those used in prior studies and included 2 strains each of L. dumoffii, L. longbeachae, and L. micdadei; 1 strain of L. bozemanii; and 15 strains of L. pneumophila (3, 4) . Staphylococcus aureus ATCC 29213 was used as a control organism for susceptibility testing. Legionellae were grown on locally made buffered charcoal yeast extract medium supplemented with 0.1% a-ketoglutarate (BCYEa) (5) . Incubation of all media was done at 35°C in humidified air. Standard powders of RP 74501-RP 74502 and erythromycin were obtained from Rhone-Poulenc Rorer, Vitry-surSeine, France, and Abbott Laboratories, North Chicago, Ill., respectively.
Agar dilution susceptibility testing was performed as described previously (7) . Briefly, antimicrobial-agent-contain- Otherwise, the broth microdilution method was performed exactly as described previously for a macrobroth method (7). * Corresponding author.
Any broth turbidity was considered evidence of growth. All testing was done in duplicate; the geometric mean value was used as the MIC. A MIC found to be less than or equal to the lowest concentration of the antimicrobial agent tested was arbitrarily defined to be the lowest concentration tested. Erythromycin was included as a control; data for the activity of this drug for the Legionella strains we tested have been presented previously (7, 8) .
Guinea pig pulmonary alveolar macrophages were harvested and purified as described previously (7). The final concentration of macrophages was -105 cells per well. Antimicrobial susceptibility testing of intracellular L. pneumophila was performed as described previously (7) . Briefly, 104 CFU of washed BCYEot plate-grown L. pneumophila was added to the purified alveolar macrophages. The bacteria and macrophages were incubated for 1 day after 1 h of incubation with shaking. Antimicrobial agents were added to their respective wells after the wells had been washed three times to remove nonadherent bacteria. Sonic extracts of two replicate, non-antimicrobial-agent-containing wells were quantitatively cultured for use as the day 1 bacterial count. Non-antimicrobial-agent-containing wells were used as growth controls. After two more days of incubation, the supernatants were sampled and quantitatively cultured; all wells were then washed to remove (4) .
The intracellular activity of RP 74501-RP 74502 and erythromycin against two L. pneumophila serogroup 1 strains grown in guinea pig alveolar macrophages is shown in Fig. 1  and 2 . Legionella pneumophila F889 was inhibited by both antimicrobial agents tested at concentrations 20.25 p,g/ml after 48 h of incubation. Strain F2111 was inhibited by RP 74501-RP 74502 at a concentration of 1.0 ,ug/ml, but not by 0.25 ,ug/ml. Erythromycin (0.25 jg/ml) was more active than was the same concentration of RP 74501-RP 74502, in contrast to the relative activities of both drugs at a higher concentration (1.0 ,ug/ml). For both bacterial strains tested, RP 74501-RP 74502 (1.0 p,g/ml) had a longer-lasting inhibi- tory effect than did the same concentration of erythromycin after drug removal by washing. The decrease in viable counts of strain F2111, after drug removal (day 3), in the presence of no antimicrobial agent or RP 74501-RP 74502 (0.25 ,ug/ml), is artifactual because of macrophage killing by the bacteria by day 3; many of the bacteria in these tissue culture wells were washed out with the damaged macrophages. Macrophage toxicity caused by antimicrobial agents alone was not observed.
These studies show that RP 74501-RP 74502 is about as active as erythromycin for both extracellular and intracellular legionellae. Both drugs were solely inhibitory, as has been observed for macrolides and other drugs previously (7) (8) (9) . For intracellular L. pneumophila infection, RP 74501-RP 74502 was more active than erythromycin when either drug was tested at a concentration of 1.0 ,ug/ml. However, the converse was true at drug concentrations of 0.25 ,ug/ml. The reason for this paradox is unknown. One possibility is that there is a threshold below which RP 74501-RP 74502 is not taken up into cells or below which it is inactive in the phagosome. It is known that RP 74501-RP 74502 is relatively unstable at 35°C at the concentrations tested, which may have led to an underestimation of its intracellular activity under the conditions of prolonged incubation used in the macrophage studies (12) .
The cellular uptake kinetics of RP 74501-RP 74502 are unknown, although a related combination streptogramin drug, RP 59500, is concentrated in J 774 cells, with a range of intracellular/extracellular concentration ratios of 10 to 50 (3). 
